Company profile
Biovica company profile
Biovica develops and commercializes blood-based biomarker assays that improve monitoring of modern cancer therapies and predict patient outcome. The company’s DiviTum™ assay, a test for accurately measuring cell proliferation, has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. Biovica aims to make best-possible-treatment from day one a reality. Biovica collaborates with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies. The company is ISO 13485 certified for Quality Management Systems. DiviTum™ is CE-labeled and MPA-registered.
Business identity
- Website
- http://biovica.com
- Contact email
- [email protected]
- Phone number
- +46 (0) 18 44 44 830
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia
- Postal code
- 752 37
- Country code
- RU
- Continent
- Europe